by David Kent | May 24, 2012
As a basic researcher in stem cell biology, one of my biggest fears is moving too quickly with cell therapies that involve primitive, still largely mysterious, cell populations. At the World Stem Cells & Regenerative Medicine Congress meeting this week, I felt...
by Stacey Johnson | May 24, 2012
My grandfather was a mathematician and chemical engineer who worked on the Manhattan Project. I dated a chemical engineer for two years. Those two associations are the full breadth of my understanding of this field of science. Apparently I took chemistry in high...
by David Kent | May 22, 2012
You might expect this article to be about creating skin grafts for burn victims or something of that ilk. Instead though, it concerns the complicated process of taking a scientific discovery in regenerative medicine and bringing that discovery through clinical trials...
by Paul Krzyzanowski | May 22, 2012
Many readers may already have heard of Health Canada’s approval of Osiris’ Prochymal, a mesenchymal stem cell treatment for severe cases of pediatric Graft versus Host Disease (GvHD), with plenty of coverage circulating around the web. GvHD is a disease where...
by Ubaka Ogbogu | May 18, 2012
The Federal Government has proposed amendments to the Assisted Human Reproduction Act, the legislation that governs embryo research, including many aspects of stem cell research. The amendments, which are contained in an omnibus budget implementation bill tabled...
by Stem Cell Network | May 16, 2012
Welcome to Signals Blog, the new home and new name for the Stem Cell Network Blog. Why the change? After nearly four years, 207 blog posts and several “best of” awards, the SCN Blog finally outgrew its dish, so to speak. Late last year, we began planning...
by Paul Krzyzanowski | May 16, 2012
Commercialization plenary summary: part 4 of 4 The last speaker of the commercialization plenary at the Till and McCulloch Meetings earlier this month was Dr. Stephen Minger from GE Healthcare, who shared GE’s perspective regarding the therapeutic and research...
by Stem Cell Network | May 11, 2012
By all accounts, the 35 entries in this year’s Cells I See Art Contest & Gallery Showing were among the best we’ve ever had. Certainly, there were more than we’d ever seen before (view them all here) — so many, in fact, that we had...
by David Kent | May 8, 2012
The final day of the 2012 Till and McCulloch Meetings was packed with great science, but a common theme definitely emerged – technological advances are changing the way we think about and perform scientific research. Keynote speaker Helen Blau issued a warning...
Comments